United States • Corporate Healthcare Collective

Elevating the Standard of Medical Aesthetics.

Avyra Medical Group is an elite healthcare operating and investment platform based in the United States. We partner with premier aesthetic practices and clinicians, pairing uncompromised medical excellence with institutional governance, disciplined financial stewardship, and transformative operational infrastructure.

Avyra Medical Group Modern Aesthetic Practice Environment
Operational Model
Physician-Autonomous Collective
Corporate Thesis
Institutional management designed specifically for high-growth medical aesthetic practices.
"Enduring leadership in medical aesthetics requires aligning sophisticated capital with genuine clinical autonomy and patient trust."
— Avyra Medical Group Operating Philosophy
Corporate Identity & Philosophy

Built on Institutional Rigor. Driven by Clinical Prestige.

Headquartered in the United States, Avyra Medical Group was founded to provide leading medical aesthetic practices with the financial sophistication, operational leadership, and strategic scale necessary to flourish in an evolving healthcare landscape.

Avyra Medical Group Corporate Identity and Aesthetics Facility Environment
99.4%
Quality Compliance & Retention

The Avyra Enterprise Thesis

The medical aesthetics industry has reached an inflection point. While patient demand for non-invasive aesthetic treatments continues to accelerate, individual practice owners face rising administrative burdens, fragmented supply chains, complex regulatory frameworks, and rapidly changing device lifecycles.

Avyra Medical Group resolves this challenge. Rather than imposing rigid corporate mandates, we operate as a collaborative platform. We provide partner practices with institutional capital, automated operational systems, advanced financial modeling, and marketing intelligence—while leaving clinical judgment entirely in the hands of board-certified clinicians.

Our governance model ensures that clinical integrity is never subordinated to short-term commercial pressures. By fostering long-term equity alignment, we build lasting healthcare enterprises characterized by clinical excellence, exceptional employee retention, and sustainable market leadership.

Foundational Doctrine

Institutional Purpose & Enduring Direction

Two governing principles that steer Avyra Medical Group's strategic growth, capital allocation, and physician partnerships across the United States.

Strategic Horizon Guiding Principle

Our Vision

To be recognized as the nation's preeminent medical aesthetics corporate group—setting the definitive industry benchmark for ethical business practices, clinician-first partnership models, and superior patient experience standards.

Operational Mandate Enterprise Commitment

Our Mission

To empower visionary aesthetic clinicians through centralized financial expertise, enterprise-grade operations, and continuous technological modernization, ensuring every affiliated practice achieves sustainable profitability and operational excellence.

Core Tenets

The Principles That Guide Us

Every corporate decision, acquisition, and strategic partnership at Avyra is anchored in four fundamental commitments.

Aesthetic Physician Consulting with Patient - Clinical Autonomy
Clinical Sovereignty

Clinical Autonomy

We believe treatment decisions must always be made by qualified practitioners. Our corporate function is strictly to empower and support, never to compromise clinical judgment.

Corporate Architecture and Financial Structure - Financial Precision
Capital Stewardship

Financial Precision

We apply disciplined capital allocation, institutional treasury governance, and transparent fiscal reporting to ensure enduring equity value for all partners.

Advanced Medical Aesthetics Technology - Verified Innovation
Evidence-Informed Advancement

Verified Innovation

We continuously evaluate emerging medical technologies, embracing only evidence-informed, regulatory-cleared devices and methodologies that advance patient care.

Confidential Patient-Physician Trust - Ethical Stewardship
Foundational Integrity

Ethical Stewardship

From patient privacy and HIPAA compliance to staff development and fair vendor relations, integrity remains our foundational operating standard.

Strategic Methodology

A Disciplined Framework for Sustainable Growth.

Avyra Medical Group’s corporate strategy integrates enterprise management, clinical quality governance, and technological modernization without making unsupported clinical claims.

Enterprise Infrastructure

Centralized Financial & Operational Excellence

We remove the administrative friction that prevents aesthetic practices from realizing their full potential. By centralizing core enterprise services, our partner practices achieve significant cost efficiencies while elevating executive decision-making.

✓
Capital Management & Financial Planning Institutional budgeting, working capital optimization, and predictive financial forecasting.
✓
Supply Chain & Group Purchasing Power Direct-from-manufacturer contracts yielding superior terms on consumables, injectables, and medical equipment.
✓
Revenue Cycle & Administrative Automation Modernized billing, patient financing integrations, and automated practice scheduling infrastructure.
Executive Financial Governance and Strategy
35% Average Operational Efficiency Improvement
Clinical Integrity

Physician-Led Advisory & Quality Framework

Quality in medical aesthetics requires structured oversight, continuous medical education, and strict adherence to federal and state health regulations. Avyra maintains a formal Clinical Advisory Council to uphold industry-leading standards.

✓
Independent Clinical Advisory Council Board-certified dermatologists and plastic surgeons directing clinical policy and provider credentials.
✓
Continuing Medical Education (CME) Support Dedicated funding and clinical mentorship programs for practitioner technique refinement and safety protocols.
✓
Regulatory Compliance & Risk Management Standardized OSHA, HIPAA, and state medical board compliance monitoring across all portfolio locations.
Clinical Quality and Regulatory Oversight
100% Board-Certified Clinical Advisory
Technological Modernization

Curated Adoption of Validated Aesthetic Science

Rather than chasing speculative trends, Avyra conducts rigorous technical and commercial vetting of all capital equipment and software before rolling them out across our network.

✓
Energy-Based Device Lifecycle Program Structured depreciation, trade-in, and acquisition roadmaps for FDA-cleared lasers, radiofrequency, and ultrasound systems.
✓
Digital Patient Experience Architecture Enterprise CRM, seamless mobile patient portals, and automated post-procedure engagement workflows.
✓
Practice Analytics & BI Intelligence Unified data dashboards tracking clinical utilization, provider productivity, and patient satisfaction benchmarks.
Validated Medical Technology and Equipment
FDA Strict Regulatory Compliance Standards
Expansion Strategy

Non-Disruptive Affiliation & Sustainable M&A

Our partnership approach is crafted to preserve the distinct reputation and patient relationships each practice has established, while empowering founders with liquidity and long-term equity participation.

✓
Brand Equity Preservation Practices retain their localized brand identity and community goodwill, strengthened by Avyra's back-office engine.
✓
Seamless Onboarding Playbook Dedicated integration managers ensure zero interruption to patient care or clinic scheduling during transitions.
✓
Founder Equity & Succession Planning Flexible transaction structures tailored to founders seeking either aggressive expansion or structured retirement horizons.
Corporate M&A and Partnership Growth
100% Seamless Operational Transition Record
EXECUTIVE PROFILE OFFICE OF THE CO-FOUNDER • AVYRA MEDICAL GROUP

Natalie Brooke Harrison

Co-Founder Capital Architecture • Strategic Enterprise Governance Master of Business Administration (MBA), Finance
Contact Executive Office
Natalie Brooke Harrison - Co-Founder of Avyra Medical Group
FOUNDING MANDATE
“Sustainable enterprise value in aesthetic medicine cannot be built through cost-cutting or clinical compromises; it is forged by empowering premier practitioners with institutional capital, operational transparency, and financial clarity.”
Natalie Brooke Harrison Co-Founder • Avyra Medical Group

Natalie Brooke Harrison is the Co-Founder of Avyra Medical Group, steering the enterprise's capital architecture, strategic growth, and multi-site operational governance. Her professional journey represents an intentional convergence of institutional corporate finance and specialized healthcare leadership.

BACKGROUND & INSIGHT

Corporate Finance & Market Opportunity

Holding an MBA with a concentration in finance, Natalie began her career analyzing complex capital allocation, enterprise valuation, and financial operations. As consumer demand for aesthetic medicine began its historic expansion, she recognized a structural vulnerability within the sector: premier aesthetic clinics were delivering extraordinary clinical artistry, yet practice founders were increasingly overwhelmed by escalating administrative complexity, supply chain fragmentation, and impersonal corporate roll-ups that compromised physician autonomy.

STRATEGY & EVOLUTION

Healthcare Leadership & Operating Philosophy

Guided by this market insight, Natalie made the pivotal decision to transition her analytical foundation directly into the healthcare space. Over years of directing corporate management and strategic expansion for multi-site aesthetic enterprises, she refined a business philosophy centered on empowering board-certified practitioners with enterprise-grade financial infrastructure rather than imposing bureaucratic constraints.

ENTERPRISE IMPACT

Value Creation & Long-Term Expansion

Today at Avyra, Natalie's cross-disciplinary mastery—spanning financial modeling, high-value device procurement, and physician equity alignment—serves as the foundational engine enabling affiliated practices to unlock enterprise value while upholding uncompromising patient care standards.

AREAS OF EXECUTIVE STEWARDSHIP

Institutional Competencies & Governance Remit

Key executive responsibilities directed by Natalie Brooke Harrison across corporate finance, clinical infrastructure, and practice development nationwide.

Finance & Capital

Finance & Financial Operations

Institutional capital allocation, balance-sheet management, practice valuation modeling, and syndicated credit facilities.

Aesthetic Business

Medical Aesthetics Business Management

High-ROI device lifecycle roadmaps, treatment unit economics, and consumables supply chain optimization.

Governance

Corporate Management & Governance

Multi-site operational infrastructure, executive accountability systems, and centralized corporate oversight.

Strategy

Strategic Planning & Roadmapping

Multi-year portfolio expansion, capital budgeting, enterprise risk mitigation, and long-term equity growth.

M&A & Expansion

Business Development & M&A

Strategic practice acquisitions, commercial technology partnerships, and physician affiliation due diligence.

People & Culture

Organizational Development

Physician equity alignment frameworks, talent acquisition, clinical-administrative harmony, and executive mentorship.

EXECUTIVE COMMITTEE & CLINICAL GOVERNANCE

Multidisciplinary Leadership. Uncompromising Standards.

Alongside our founding partners, Avyra’s executive leadership unites board-certified surgical oversight, enterprise operational stewardship, and medical technology vetting—empowering partner practices across the nation.

ENTERPRISE ALLIANCES INSTITUTIONAL SYNDICATE ARCHITECTURE

Strategic Partnerships & Practice Affiliation.

Avyra Medical Group partners with top-tier aesthetic physicians, medical technology innovators, and institutional capital providers to accelerate collective success across the United States.

Three Integrated Models | Nationwide Operating Scale | Physician Sovereignty
FLAGSHIP ALLIANCE • FOUNDING MANDATE
CLINICIAN PLATFORM • CORE FRAMEWORK

Practice Affiliation & Equity Partnerships

Tailored for high-performing aesthetic clinics seeking partial or full equity monetization while retaining clinical leadership and practice culture.

  • Upfront liquidity with ongoing equity appreciation
  • Immediate access to enterprise purchasing rates
  • Complete back-office and marketing support
  • Full preservation of clinical protocol autonomy
CAPITAL EQUIPMENT & BIOTECH
VECTOR 02
MEDICAL INNOVATION • CLINICAL ADOPTION

Device & Technology Alliances

Collaborative integration pathways for medical device manufacturers and biotech firms seeking rapid clinical adoption across our nationwide network.

  • Multi-site evaluation and rapid protocol deployment
  • Real-world clinical utilization feedback
  • Coordinated provider training and certification
  • Structured fleet procurement and lease governance
INSTITUTIONAL SYNDICATE
VECTOR 03
CAPITAL ALLOCATION • PORTFOLIO SCALE

Strategic Capital & Co-Investments

Institutional partnerships designed for healthcare family offices and private equity syndicates seeking disciplined exposure to high-growth aesthetic medicine.

  • Institutional-grade audit and financial governance
  • Proven M&A sourcing and integration pipeline
  • Defensive unit economics with premium margins
  • Transparent quarterly performance reporting
Validated Network

Existing Alliances & Institutional Partners

Technology & Systems

Synergy Aesthetic Systems

National partner for next-generation energy-based aesthetic systems and radiofrequency micro-needling platforms.

Fleet Procurement & Clinical Protocol Standardization
Institutional Capital

Apex Healthcare Capital

Growth equity partner providing dedicated debt facilities and balance-sheet capacity for regional practice acquisitions.

M&A Financing & Financial Risk Advisory
Clinical Research

Lumina Aesthetics Research

Academic collaboration group conducting post-market clinical observational trials and aesthetic safety evaluations.

Clinical Efficacy Audits & CME Curriculum
Regenerative Formulations

Novellus Dermascience

Formulation partner developing pharmaceutical-grade topical serums, post-procedure recovery matrices, and physician-dispensed skincare.

Exclusive Clinic Network Distribution
Practice Intelligence

Ascend Health Technologies

Enterprise EHR and patient scheduling optimization system unifying multi-location clinical records and compliance tracking.

Centralized Practice Management Architecture
Clinical Governance

Veritas Clinical Advisory

Independent physician review organization offering third-party quality audits and clinician credentialing verification.

National Quality Assurance & Credentialing
Direct Engagement

Connect With Our Executive Team.

Whether you are a practice founder seeking an affiliation discussion, an institutional investor, or an industry partner, we invite you to start a confidential dialogue.

Practice Affiliation & M&A

partnerships@avyramedical.com

Corporate & Executive Office

corporate@avyramedical.com

Telephone Inquiries

+1 (800) 492-AVYRA • +1 (212) 555-0198

Corporate Headquarters & Regional Offices
New York Headquarters
550 Madison Avenue, 28th Floor
New York, NY 10022
United States
West Coast Executive Office
9465 Wilshire Boulevard, Suite 700
Beverly Hills, CA 90212
United States
Open in Google Maps
550 Madison Avenue, 28th Floor • New York, NY 10022, USA
PRIMARY HEADQUARTERS
CONFIDENTIAL INQUIRY DESK
DIRECT ACCESS

Initiate Corporate Inquiry

Prospective practice founders, clinical leaders, and institutional healthcare investors are invited to initiate direct, confidential communications with our executive team through our primary corporate pathways.

VECTOR 01 PRACTICE FOUNDERS & CLINICIANS

Practice Affiliation & M&A

For high-performing practice founders exploring equity monetization, operational scale, and physician-led succession.

VECTOR 02 INSTITUTIONAL INVESTORS & ALLIANCES

Corporate & Executive Office

For institutional private equity syndicates, biotechnology partners, capital equipment providers, and corporate affairs.

VECTOR 03 DIRECT EXECUTIVE SWITCHBOARD

Telephone Inquiries

Direct confidential access to our executive offices in New York and Beverly Hills during standard business hours.

Strict Confidentiality Notice: All initial dialogues are treated as proprietary corporate correspondence and safeguarded by institutional non-disclosure standards.